Renru Luo

机构：Sun Yat-sen University

发表论文 6 篇 · 总被引 64 次 · h-index 3

代表论文

• The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants (2022 · Science Translational Medicine · 被引 44)
• LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA (2023 · Life Sciences · 被引 12)
• YAP Alleviates Pulmonary Fibrosis Through Promoting Alveolar Regeneration via Modulating the Stemness of Alveolar Type 2 Cells (2024 · Stem Cells and Development · 被引 6)
• c-Rel is a Novel Oncogene in Lung Squamous Cell Carcinoma Regulating Cell Proliferation and Migration (2024 · Journal of Cancer · 被引 1)
• Lncrna HHIP-AS1 Suppresses Lung Squamous Cell Carcinoma by Stabilizing HHIP mRNA (2023 · SSRN Electronic Journal · 被引 1)
• A novel mouse model of pulmonary fibrosis: twice-repeated oropharyngeal bleomycin administration mimicking human pathology (2025 · Biochemistry and Cell Biology)